New biomarkers for 1,1-dimethylhydrazine
Authors:
- Anton Igorevich UkolovAUAnton Igorevich Ukolov
- Denis Sergeevich LaptevDLDenis Sergeevich Laptev
- Evgeny Yurievich KarmanovEKEvgeny Yurievich Karmanov
- Georgy Vasilyevich KarakashevGKGeorgy Vasilyevich Karakashev
- Denis Viktorovich KrivorotovDKDenis Viktorovich Krivorotov
- Dmitry Vladimirovich BobkovDBDmitry Vladimirovich Bobkov
- Sergey Gervasievich PetunovSPSergey Gervasievich Petunov
- 30 June 2022
- journal article
- research article
- Published by Federal Scientific Center for Hygiene F.F.Erisman in Toxicological Review
- Vol. 30 (3) , 182-190
Abstract
Introduction. Despite the large-scale use of asymmetric dimethylhydrazine (UDMH) in the domestic rocket and space industry, its biomarkers of exposure in blood plasma and urine, as well as biomarkers of cardiotoxic effects, have not yet been described. Material and methods. The study of blood and urine samples of rats after a single injection of 10 mg/kg UDMH (1/16 LD50) was carried out by HPLC-MS. The determination of the non-metabolized form of UDMH was also carried out using the method of gas chromatography with mass-selective detection with preliminary derivatization with 4-pyridinecarboxyaldehyde. The cardiotoxic effect of UDMH was assessed on a model of an isolated rat heart with subchronic intragastric administration for 28 days at doses of 0,02; 0,2; 2,0 mg/kg. Results. It has been established that the main metabolites of UDMH are dimethylhydrazones of pyridoxal (vitamin B6) and pyruvic acid (pyruvate). The possibility of determining the non-metabolized form of UDMH in blood and urine by HPLC-MS was shown, concentrations reach 10-60 ng/ml of blood plasma and 200-2000 ng/ml. The use of UDMH leads to an increase in the mass coefficient of the heart at a dose of 2,0 mg/kg. In ex vivo experiments on the rat heart, the cardiotoxic effect of UDMH was shown at subchronic use at a dose of 0,2 mg/kg and above, expressed in significant dilatation of the coronary bloodstream and left ventricle, the development of pronounced negative inotropic and chronotropic effects, and a decrease in the maximum rate of contraction and relaxation of the left ventricle. ventricle, reflecting the inhibition of myocardial energy metabolism. Limitations of the study. In the work, biomarkers were detected after a single intragastric injection of NDMG, the toxicokinetic characteristics of biomarkers and their retrospectivity were not evaluated. Conclusion. The main metabolites of UDMH with intravenous administration of 1/16 DL50 are dimethylhydrazones of pyridoxal (vitamin B6) and pyruvic acid (pyruvate). With subchronic administration, UDMH has cardiotoxicity at a dose of 0,02 mg/kg and above.Keywords
This publication has 6 references indexed in Scilit:
- Efficiency of inosine glycyl-cysteinyl-glutamate disodium and pyridoxine in acute poisoning by unsymmetrical dimethylhydrazineBulletin of the Russian Military Medical Academy, 2018
- HYDRAZINE AND ITS DERIVATIVES: TOXICOLOGICAL CHARACTERISTICSСовременные проблемы науки и образования (Modern Problems of Science and Education), 2017
- GC-MS determination of hydroxylamine in blood and urineVestnik of Saint Petersburg University. Physics. Chemistry, 2017
- The influence of β-endorphin on the functional activity of the isolated heart of rat. The role of δ-opioid receptorsRegional blood circulation and microcirculation, 2015
- Identification of isomeric alkylarenes with the use of additive relations for the evaluation of gas-chromatographic retention indicesJournal of Analytical Chemistry, 2011
- Coding of the Structural Features of Organic Compounds for the Estimation of Chromatographic Retention Indices With the USE of Additive SchemesJournal of Structural Chemistry, 2010